ATC Group: C07AB07 Bisoprolol

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of C07AB07 in the ATC hierarchy

Level Code Title
1 C Cardiovascular system
2 C07 Beta blocking agents
3 C07A Beta blocking agents
4 C07AB Beta blocking agents, selective
5 C07AB07 Bisoprolol

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Route Amount
ORAL - Oral 10 mg

Active ingredients in C07AB07

Active Ingredient Description
Bisoprolol

Bisoprolol is a potent highly beta1-selective-adrenoceptor blocking agent, lacking intrinsic stimulating and without relevant membrane stabilising activity.

Related product monographs

Title Information Source Document Type  
BISOCOR Tablet Health Products Regulatory Authority (IE) MPI, EU: SmPC
CARDICOR Film-coated tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
CONCOR Film-coated tablet Υπουργείο Υγείας (CY) MPI, EU: SmPC
EMCOR Film-coated tablet MPI, EU: SmPC

Medicines in this ATC group

Australia (AU)

Cyprus (CY)

Estonia (EE)

Finland (FI)

Hong Kong (HK)

Ireland (IE)

Israel (IL)

Japan (JP)

Lithuania (LT)

Mexico (MX)

Netherlands (NL)

New Zealand (NZ)

Nigeria (NG)

Spain (ES)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.